Contact

Start with the line that is costing you the most.

Tell us the press, the coater or the granulator, the number that hurts and who owns it. The first call is a line review: your equipment, PAT and MES stack, the wedge workflow we would shadow first, and what QA will want to see.

hello@pildeon.comReply within two business daysNo drip campaign

run_b2c7e1 · agent graph · scenario 10 nodes · 1 QA approval gate
01 · orchestrator ingest.batch_record ✓ SUCCEEDED 02 · orchestrator twin.rehearse ✓ SUCCEEDED 03 · blend_dispense blend.uniformity ✓ SUCCEEDED 04 · granulate_dry granulate.dry ✓ SUCCEEDED 05 · compress_fill compress.press ✓ SUCCEEDED 06 · coat_dry coat.spray ✓ SUCCEEDED 07 · defect_inspect inspect.tablets ✓ SUCCEEDED 08 · quality_potency spectra.release_evidence ✓ SUCCEEDED 09 · orchestrator approve.qa ◆ APPROVAL 10 · quality_conf release.genealogy ✓ SUCCEEDED

Scenario: Run one immediate-release tablet batch through granulation, compression, coating and inspection inside the approved design space, with QA approval before release. A design walkthrough, not a customer record.

Contact

Tell us about your line

The more specific the line and the problem, the more useful the first call is. Every field is optional except the ones marked required.

Required.

Required. We reply from a pildeon.com address.

Group name is fine if you prefer.

Helps us bring the right person to the call.

Press, coater or granulator make, PAT and MES systems, dosage forms, if you have them to hand.

Required. Reject rate, deviations, release time, drying energy, a retiring formulator, whatever is actually hurting.

The form opens your mail client addressed to hello@pildeon.com. We reply within two business days. No sequence, no drip campaign.

Other routes

Email
hello@pildeon.com
Design partners
What we ask and what you get
Partners
Equipment, PAT, MES, integrators
Candidates
Roles we are hiring for
Security pack
Ask for it by email; it goes to your QA and IT security review

Headquarters and a postal address will be published when the company is formed. Until then, email is the route.

Reasons

Why people get in touch

Pick the closest.

Line review

I want to know where to start

Bring the line and the number. We map the wedge, the stack and the stakeholders.

Design partnership

I want shadow mode on one workflow

We scope the baseline, the connectors and the QA involvement, and write the exchange down.

Security and validation

QA and IT need the pack

Architecture, data flows, audit-trail schema, validation approach and GAMP 5 package status.

Partnership

I make or integrate the equipment

OEMs, PAT and MES vendors, integrators and CSV consultancies.

Investment

I want the investor summary

Thesis, market, defensibility and the design-partner plan, with targets labelled.

Careers

I want to own a product or a layer

Tell us which and what you have built that is closest to it.

Run timeline · scenario

What we would be deploying

This is the shape of the run your line would produce once the wedge workflow graduates from shadow mode.

run_b2c7e1 Line 2 · rotary tablet press · scenario SUCCEEDED
  1. 01 ingest.batch_record SUCCEEDED 1.2 s

    Plant Orchestrator · Pulled the master batch record, the approved design-space limits for this formulation and tooling family, and the site autonomy policy from MES; locked the target envelope for the run.

  2. 02 twin.rehearse SUCCEEDED 41 s

    Plant Orchestrator · Twindra simulated 36 candidate setpoint vectors on the as-made batch twin (granulation DEM, compression and ejection risk, coating CFD, dissolution surrogate) and ranked them on predicted content uniformity, capping risk and takt.

  3. 03 blend.uniformity SUCCEEDED 6 m 10 s

    Blend-and-Dispense · Spectryn scored in-line NIR spectra against the formulation's chemometric model; the blend reached its uniformity end point with confidence bounds inside the site acceptance limit and blending stopped on evidence rather than on a fixed time.

  4. 04 granulate.dry SUCCEEDED 3 m 48 s

    Granulate-and-Dry · Inlet air temperature and drying airflow trimmed inside the approved window to bring loss-on-drying to the target moisture band for compression; the move was bounded, logged and inside the design space.

  5. 05 compress.press SUCCEEDED 2 m 02 s

    Compress-and-Fill · Main compression force and feed-frame speed adjusted inside the approved window to hold tablet weight and hardness on target while the twin's capping-risk estimate stayed under the site threshold.

  6. 06 coat.spray SUCCEEDED 4 m 25 s

    Coat-and-Dry · Spray rate and inlet temperature re-phased against bed temperature and exhaust humidity to hold the film-coat window and avoid twinning and mottling; no excursion from the validated recipe envelope.

  7. 07 inspect.tablets SUCCEEDED continuous

    Defect-and-Inspect · Visqa classified chips, cracks, capping, spots, mottling and print defects on six synchronised cameras, within the sub-100 ms design budget, and linked a rising chip rate to coating spray rather than to tooling.

  8. 08 spectra.release_evidence SUCCEEDED 38 s

    Quality-and-Potency · Spectryn assembled the method-linked evidence chain for content uniformity and moisture with confidence bounds and citations to the validated analytical method, ready for QA review.

  9. 09 approve.qa APPROVAL 3 m 14 s

    Plant Orchestrator · Batch release is above every autonomy level Pildeon offers. The package was held for the named QA reviewer, who approved it in the review console; the decision, the reviewer identity and the timestamp are in the Part 11 audit trail.

  10. 10 release.genealogy SUCCEEDED 52 s

    Quality-and-Conformance · Conforma wrote the time-aligned batch genealogy (every sensor state, recommendation, approved action, equipment response and QC result) and the cited release package to the immutable audit trail.

The engagement

What a design partnership looks like

Phases, not promises of dates; your validation calendar sets the pace.

  1. Line review and wedge selection, with your MSAT champion and QA reviewer named.
  2. Read-only connection and historical extract for the baseline.
  3. Shadow mode: predictions against QC, weekly, nothing written.
  4. Assist mode: recommendations in the review console; engineers enter the moves; ROI measured.
  5. Decision on a written metric: paid validated pilot, or stop with the baseline report in hand.
Enterprise

Standardise validated autonomy across the group

One policy model, one audit spine, one benchmark across every line in every plant, with formulation and tooling models kept private to each site.

Talk to the team Enterprise details

  • SSO, RBAC and named approvers down to the setpoint level
  • Group autonomy policy with per-site override and approval chains
  • Cross-plant benchmarking on yield, rejects, deviations and energy
  • Validated on-prem and air-gapped plant-edge deployment options
  • Validation packages and change-control records as first-class deliverables
  • Dedicated deployment engineer and quarterly model review per site
Pricing

Priced per line, per plant, per group

Land on one validated workflow with a measurable baseline. Expand by line, module, site and autonomy level. Outcome components are available on yield, rejects, deviations and energy.

Billing period
Line $17,000 per compression, coating or granulation line / month · billed monthly

Compression or coating control or inspection AI for one line. For OSD makers validating ROI on the wedge.

  • One line, one agent module
  • Validated plant-edge inference node
  • Equipment, PAT and MES read; bounded write inside the design space
  • Run log, Part 11 audit trail, batch genealogy
  • Business-hours support
Start a validated pilot
Enterprise Custom land $750k to $10M ACV

Pharma and CDMO groups standardising on Pildeon across sites, with custom formulation, tooling and tolerance models.

  • Multi-site validated plant-edge fleet
  • Custom formulation, tooling and tolerance models
  • Validated on-prem deployment, air-gapped option
  • Group autonomy policy and approval chains
  • SLAs, SSO and RBAC, dedicated engineer
Contact us

Annual prepay discounts run 15 to 20% depending on term; the toggle shows 15%. Usage metering applies above plan limits. Multi-year enterprise agreements carry usage ramps.

Guardrails

An agent that can move a compression force needs a leash

Pildeon writes to production equipment in a GMP plant. Every capability is scoped to the approved design space, every write is policy-checked, every action is written to an immutable Part 11 audit trail the site owns, and no agent can release a batch.

  • Bounded action space. Each agent can only write to an explicit setpoint allow-list, inside the limits the site's validation approved.
  • Policy engine before every write. Autonomy level, design-space limits, batch state, model version and reviewer assignment are all evaluated before a setpoint moves.
  • Human-in-the-loop gates. Batch release, any move outside the design space and any change to a validated parameter wait for a named QA reviewer.
  • Immutable audit trail. Append-only, hash-chained, exportable, retained on the site's own storage, with reviewer identity and timestamp on every decision.
  • Hard fallback. Loss of the edge node, the network or the model returns the line to the equipment's last known-good recipe.
  • Tenant and IP isolation. Formulations, recipes and models never cross a customer boundary. Validated on-prem deployment is available for regulated producers.

Compliance posture

Compliance and validation status
StandardScopeStatus
21 CFR Part 11Audit trail, e-signatures, records RUNNING Designed in from day one
GAMP 5Validation package for the platform RUNNING In progress, planned for the first design partners
cGMP · ICH Q8 to Q13Design space, QbD, continuous manufacturing RUNNING Design-aligned; site validation decides
SOC 2 Type ICloud control plane QUEUED Planned, first six months
SOC 2 Type IICloud control plane QUEUED Planned, months six to twelve
Data residencyValidated on-prem, air-gapped option SUCCEEDED Available by design

Read the security and validation overview

The first meeting

What each stakeholder asks first

Pildeon has no customer quotes to show yet, and will not invent any. These are the questions the three buyers in an OSD plant ask in the first meeting, and the answer each gets.

"What does this do to my reject rate, my deviation count and my release time, and how will you prove it on my line rather than on a slide?"

Site or manufacturing director · economic buyer

Answer: shadow mode first, baseline captured before any autonomous action, a written ROI target before a paid pilot.

"Will it ever move a setpoint outside the design space we validated, and can I see why it recommended every move it made?"

Formulation or process engineer (MSAT) · champion

Answer: no, by construction. Every recommendation carries its reasoning trace and its citation.

"Where is the Part 11 audit trail, who signs the release, and what happens to my validated state when the model changes?"

QA, quality and compliance lead · approver

Answer: an immutable audit spine, a named QA reviewer on every release, and every model change under GxP change control.

Integrations

It speaks tablet plant, not cloud

Pildeon reads and writes through the systems already on the floor: presses, coaters, granulators, PAT probes, MES, LIMS and historians. No rip-and-replace, no parallel historian. Connectors are built with design partners against their stacks; the vendors listed are the ones common in OSD plants.

Blending and granulation

GEA, Glatt, Syntegon, Freund-Vector, L.B. Bohle

Blender, granulator and fluid-bed telemetry; bounded setpoint writes

Tablet presses and fillers

Fette Compacting, Korsch, IMA, Syntegon, MG2

Force curves, fill depth, ejection force; bounded setpoint writes

Coating systems

GEA, Glatt, O'Hara, Thomas, Freund

Spray, inlet, bed temperature, exhaust humidity; bounded writes

PAT and NIR

Bruker, Sartorius, Viavi probes and analysers

Spectra across blend, granulation, drying and compression

Vision

Line cameras and existing inspection systems

Frames, defect maps, reviewed images

Pharma MES and eBR

Körber Werum PAS-X, Rockwell, Siemens Opcenter

Master batch records, campaigns, batch genealogy

LIMS and historians

Site LIMS, OSIsoft PI and equivalent historians

QC results, time-series backfill and replay

Identity and edge

Azure AD, Okta, LDAP · NVIDIA Jetson and on-prem GPU

SSO, RBAC, named approvers · inference at the line

See all integrations

FAQ

Straight answers

The questions site directors, MSAT engineers and QA leads actually ask in the first meeting.

Yes, but only inside an explicit setpoint allow-list bounded by the design space your validation approved, and only at the autonomy level your site has set. Level 0 is shadow mode: Pildeon observes and predicts and writes nothing. Most sites spend their first weeks there.

Get started

Or just send the line details

One email to hello@pildeon.com with the press, the number and the names. We take it from there.